<table width="75%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2.  Pharmacokinetic Parameters of Linezolid in Pediatrics and Adults Following a Single Intravenous Infusion of 10 mg/kg or 600 mg Linezolid (Mean: (%CV); [Min, Max Values])</caption>
<col align="left" span="1" valign="middle" width="30%"></col>
<col align="center" span="1" valign="middle" width="14%"></col>
<col align="center" span="1" valign="middle" width="14%"></col>
<col align="center" span="1" valign="middle" width="14%"></col>
<col align="center" span="1" valign="middle" width="14%"></col>
<col align="center" span="1" valign="middle" width="14%"></col>
<tbody>
<tr>
<th colspan="1">
<br/>Age Group</th>
<th colspan="1">C<sub>max</sub>
<br/>µg/mL</th>
<th colspan="1">V<sub>ss</sub>
<br/>L/kg</th>
<th colspan="1">AUC<linkhtml href="#footnote-1">*</linkhtml>
<br/>µg•h/mL</th>
<th colspan="1">t <sub>1/2</sub>
<br/>hrs</th>
<th colspan="1">CL<br/>mL/min/kg</th>
</tr>
<tr>
<td>Neonatal Patients<br/>  Pre-term<linkhtml href="#footnote-2">†</linkhtml>
<br/>  &lt; 1 week (N=9)<linkhtml href="#footnote-3">‡</linkhtml>
</td>
<td>
<br/>12.7 (30%)<br/>[9.6, 22.2]</td>
<td>
<br/>0.81 (24%)<br/>[0.43, 1.05]</td>
<td>
<br/>108 (47%)<br/>[41, 191]</td>
<td>
<br/>5.6 (46%)<br/>[2.4, 9.8]</td>
<td>
<br/>2.0 (52%)<br/>[0.9, 4.0]</td>
</tr>
<tr>
<td>  Full-term<linkhtml href="#footnote-4">§</linkhtml>
<br/>  &lt; 1 week (N=10)<footnoteref idref="A"></footnoteref>
</td>
<td>
<br/>11.5 (24%)<br/>[8.0, 18.3]</td>
<td>
<br/>0.78 (20%)<br/>[0.45, 0.96]</td>
<td>
<br/>55 (47%)<br/>[19, 103]</td>
<td>
<br/>3.0 (55%)<br/>[1.3, 6.1]</td>
<td>
<br/>3.8 (55%)<br/>[1.5, 8.8]</td>
</tr>
<tr>
<td>  Full-term<footnoteref idref="B"></footnoteref>
<br/>  ≥ 1 week to ≤ 28 days (N=10)<footnoteref idref="A"></footnoteref>
</td>
<td>
<br/>12.9 (28%)<br/>[7.7, 21.6]</td>
<td>
<br/>0.66 (29%)<br/>[0.35, 1.06]</td>
<td>
<br/>34 (21%)<br/>[23, 50]</td>
<td>
<br/>1.5 (17%)<br/>[1.2, 1.9]</td>
<td>
<br/>5.1 (22%)<br/>[3.3, 7.2]</td>
</tr>
<tr>
<td>Infant Patients<br/>  &gt; 28 days to &lt; 3 Months (N=12 )<footnoteref idref="A"></footnoteref>
</td>
<td>
<br/>11.0 (27%)<br/>[7.2, 18.0]</td>
<td>
<br/>0.79 (26%)<br/>[0.42, 1.08]</td>
<td>
<br/>33 (26%)<br/>[17, 48]</td>
<td>
<br/>1.8 (28%)<br/>[1.2, 2.8]</td>
<td>
<br/>5.4 (32%)<br/>[3.5, 9.9]</td>
</tr>
<tr>
<td>Pediatric Patients<br/>  3 months through 11 years<footnoteref idref="A"></footnoteref> (N=59)</td>
<td>
<br/>15.1 (30%)<br/>[6.8, 36.7]</td>
<td>
<br/>0.69 (28%)<br/>[0.31, 1.50]</td>
<td>
<br/>58 (54%)<br/>[19, 153]</td>
<td>
<br/>2.9 (53%)<br/>[0.9, 8.0]</td>
<td>
<br/>3.8 (53%)<br/>[1.0, 8.5]</td>
</tr>
<tr>
<td>Adolescent Subjects and Patients<br/>  12 through 17 years<linkhtml href="#footnote-5">¶</linkhtml> (N=36)</td>
<td>
<br/>16.7 (24%)<br/>[9.9, 28.9]</td>
<td>
<br/>0.61 (15%)<br/>[0.44, 0.79]</td>
<td>
<br/>95 (44%)<br/>[32, 178]</td>
<td>
<br/>4.1 (46%)<br/>[1.3, 8.1]</td>
<td>
<br/>2.1 (53%)<br/>[0.9, 5.2]</td>
</tr>
<tr>
<td>Adult Subjects<linkhtml href="#footnote-6">#</linkhtml> (N= 29)</td>
<td>12.5 (21%)<br/>[8.2, 19.3]</td>
<td>0.65 (16%)<br/>[0.45, 0.84]</td>
<td>91 (33%)<br/>[53, 155]</td>
<td>4.9 (35%)<br/>[1.8, 8.3]</td>
<td>1.7 (34%)<br/>[0.9, 3.3]</td>
</tr>
</tbody>
</table>